Modified iRNA agents

Details for Australian Patent Application No. 2009213011 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Manoharan, Muthiah

Agent Griffith Hack

Pub. Number AU-B-2009213011

Parent 2004233092

Filing date 7 September 2009

Wipo publication date 8 October 2009

Acceptance publication date 19 January 2012

International Classifications

C07D 473/14 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/70 (2006.01) - Carbohydrates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

1 October 2009 Complete Application Filed

8 October 2009 Application Open to Public Inspection

  Published as AU-B-2009213011

19 January 2012 Application Accepted

  Published as AU-B-2009213011

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009213012-Method of soldering a polymer surface with a conducting or semi-conducting surface and applications of same

2009213010-Transportable enclosures for animals